SCHEMBL7140591

SCHEMBL7140591

CN1CCCN(CCOc2cccc(-c3n[nH]c4c3Cc3ccccc3-4)c2)CC1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.64
CHEK1 O14757 9/20 0.52
MAP4K4 O95819 1/20 0.49
RET P07949 1/20 0.49
PHKG2 P15735 1/20 0.49
RPS6KB1 P23443 1/20 0.49
MARK3 P27448 1/20 0.49
FLT3 P36888 1/20 0.49
RPS6KA3 P51812 1/20 0.49
PRKAA1 Q13131 1/20 0.49
MELK Q14680 1/20 0.49
MARK2 Q7KZI7 1/20 0.49
MINK1 Q8N4C8 1/20 0.49
BRSK1 Q8TDC3 1/20 0.49
AURKB Q96GD4 1/20 0.49
LTA4H P09960 1/20 0.48
KCNH2 Q12809 1/20 0.48
BACE1 P56817 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147004 0.96 KDR (0.68) KDRCHEK1MAP4K4RETPHKG2
SCHEMBL7702402 0.95 KDR (0.63) KDRCHEK1MARK3FLT3MARK2
SCHEMBL7147015 0.93 KDR (0.59) KDRCHEK1MAP4K4RETPHKG2
SCHEMBL7700924 0.92 KDR (0.67) KDRCHEK1RETMARK3FLT3
SCHEMBL7703072 0.89 KDR (0.55) KDRCHEK1MAP4K4RETPHKG2
SCHEMBL7172093 0.89 KDR (0.58) KDRCHEK1MAP4K4RETPHKG2
SCHEMBL7703663 0.89 CHEK1 (0.62) KDRCHEK1RETMARK3RPS6KA3
SCHEMBL7699601 0.88 CHEK1 (0.62) KDRCHEK1MAP4K4RETPHKG2
SCHEMBL7702307 0.85 KDR (0.54) KDRCHEK1RETMARK3FLT3
SCHEMBL7702517 0.84 KDR (0.57) KDRCHEK1MAP4K4RETPHKG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed